These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9063344)

  • 41. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complementary/alternative and conventional medicine use amongst menopausal women: results from the Australian Longitudinal Study on Women's Health.
    Peng W; Adams J; Hickman L; Sibbritt DW
    Maturitas; 2014 Nov; 79(3):340-2. PubMed ID: 25190368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Menopausal symptoms after the discontinuation of long-term hormone replacement therapy in women under 60: a 3-year follow-up.
    Perrone G; Capri O; Galoppi P; Patacchioli FR; Bevilacqua E; de Stefano MG; Brunelli R
    Gynecol Obstet Invest; 2013; 76(1):38-43. PubMed ID: 23711663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
    Parazzini F;
    Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Compliance of hormone replacement therapy in menopausal women].
    Pereiró Berenguer I; Sanfélix Genovés J; García Cervera J; Furió Bonet S; Vicente Polo JM; Martínez Mir I
    Med Clin (Barc); 2001 Jul; 117(6):207-10. PubMed ID: 11481094
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
    Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
    J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thoughts on individualizing hormone replacement therapy based on the postmenopausal health disparities study data.
    Gavaler JS
    J Womens Health (Larchmt); 2003 Oct; 12(8):757-68. PubMed ID: 14588126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of sexual dysfunction in a cohort of middle-aged women: influences of menopause and hormone replacement therapy.
    Castelo-Branco C; Blumel JE; Araya H; Riquelme R; Castro G; Haya J; Gramegna G
    J Obstet Gynaecol; 2003 Jul; 23(4):426-30. PubMed ID: 12881088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differences in the lipid profile and hormone replacement therapy use in Korean postmenopausal women: the Korea National Health and Nutrition Examination Survey (KNHANES) 2010-2012.
    Ki EY; Hur SY; Park JS; Do Han K; Park YG
    Arch Gynecol Obstet; 2016 Jul; 294(1):165-73. PubMed ID: 26688284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.
    Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG
    Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can we measure prior postmenopausal estrogen/progestin use? The Postmenopausal Estrogen/Progestin Interventions Trial. The PEPI Investigators.
    Greendale GA; James MK; Espeland MA; Barrett-Connor E
    Am J Epidemiol; 1997 Nov; 146(9):763-70. PubMed ID: 9366624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hormonal replacement therapy in menopausal women with a history of hyperprolactinemia.
    Touraine P; Deneux C; Plu-Bureau G; Mauvais-Jarvis P; Kuttenn F
    J Endocrinol Invest; 1998 Dec; 21(11):732-6. PubMed ID: 9972671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause].
    Perrone G; Capri O; Borrello M; Galoppi P
    Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors predicting current use of hormone replacement therapy among menopausal Jewish women in Israel. The National Women's Health Interview Survey, 1998.
    Merom D; Ifrah A; Cohen-Manheim I; Chinich A; Green MS
    Isr Med Assoc J; 2002 Sep; 4(9):671-6. PubMed ID: 12440227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The management of menopause in women with a history of endometriosis: a systematic review.
    Gemmell LC; Webster KE; Kirtley S; Vincent K; Zondervan KT; Becker CM
    Hum Reprod Update; 2017 Jul; 23(4):481-500. PubMed ID: 28498913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
    Stampfer MJ; Colditz GA; Willett WC; Manson JE; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1991 Sep; 325(11):756-62. PubMed ID: 1870648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
    Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 Jun; 5(6):513-54. PubMed ID: 10147266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.